Advertisement

Drugs & Therapy Perspectives

, Volume 35, Issue 12, pp 607–611 | Cite as

Patchy evidence in skin-picking disorder supports management with combined behavioural and drug treatments

  • Adis Medical WritersEmail author
Disease Management
  • 18 Downloads

Abstract

Skin-picking disorder (SPD) is a common, repetitive, compulsive and distressing disorder with significant psychosocial effects. Data from relatively few clinical trials support behavioural therapies, especially habit-reversal therapy, as the first-line treatment. Depending on the individual’s SPD style and comorbidities, augmenting habit-reversal therapy with other behavioural therapies or pharmacological options, particularly glutamatergic modulators or specific serotonin-reuptake inhibitors, may enhance treatment outcomes.

Notes

Compliance with ethical standards

Funding

The preparation of this review was not supported by any external funding.

Conflict of interest

The article was adapted from CNS Drugs; 2019:33(4):337–46 [1] by employees of Adis International Ltd./Springer Nature, who are responsible for the article content and declare no conflicts of interest.

References

  1. 1.
    Jafferany M, Patel A. Skin-picking disorder: a guide to diagnosis and management. CNS Drugs. 2019;33(4):337–46.CrossRefGoogle Scholar
  2. 2.
    Diagnostic and statistical manual of mental disorders (DSM-5). Washington DC: American Psychiatric Association; 2013.Google Scholar
  3. 3.
    Arnold LM, Auchenbach MB, Mcelroy SL. Psychogenic excoriation. CNS Drugs. 2001;15(5):351–9.CrossRefGoogle Scholar
  4. 4.
    Gupta A, Jafferany M. Psychocutaneous disease. In: Sadock BJ, Sadock VA, Ruiz P, editors. Kaplan and Sadock’s comprehensive textbook of psychiatry. 10th ed. Philadelphia: Lippincott William & Wilkins; 2000.Google Scholar
  5. 5.
    Koo JYM, Lee CS. General approach to evaluating psychodermatological disorders. In: Koo JYM, Lee CS, editors. Psychocutaneous medicine. New York: Marcel Dekker, Inc.; 2003. p. 1–29.Google Scholar
  6. 6.
    Jones G, Keuthen N, Greenberg E. Assessment and treatment of trichotillomania (hair pulling disorder) and excoriation (skin picking) disorder. Clin Dermatol. 2018;36(6):728–36.CrossRefGoogle Scholar
  7. 7.
    Gupta M. Body-focused repetitive behaviors (BFRB) (trichotillomania, skin picking, onychophagia) and eating disorders (ED): preliminary findings in a nondermatologic sample. J Am Acad Dermatol. 2016;74(5):46.Google Scholar
  8. 8.
    Ricketts EJ, Snorrason Í, Kircanski K, et al. A latent profile analysis of age of onset in pathological skin picking. Compr Psychiatry. 2018;87:46–52.CrossRefGoogle Scholar
  9. 9.
    Keuthen NJ, Tung ES, Woods DW, et al. Replication study of the Milwaukee inventory for subtypes of trichotillomania-adult version in a clinically characterized sample. Behav Modif. 2015;39(4):580–99.CrossRefGoogle Scholar
  10. 10.
    Snorrason I, Smári J, Olafsson RP. Emotion regulation in pathological skin picking: findings from a non-treatment seeking sample. J Behav Ther Exp Psychiatry. 2010;41(3):238–45.CrossRefGoogle Scholar
  11. 11.
    Schuck K, Keijsers GP, Rinck M. The effects of brief cognitive-behaviour therapy for pathological skin-picking: a randomised comparison to wait-list control. Behav Res Ther. 2011;49(1):11–7.CrossRefGoogle Scholar
  12. 12.
    Teng EJ, Woods DW, Twohig MP. Habit reversal as a treatment for chronic skin picking: a pilot investigation. Behav Modif. 2006;30(4):411–22.CrossRefGoogle Scholar
  13. 13.
    Flessner CA, Busch AM, Heideman PW, et al. Acceptance enhanced behavior therapy (AEBT) for trichotillomania and chronic skin picking: exploring the effects of component sequencing. Behav Modif. 2008;32(5):579–94.CrossRefGoogle Scholar
  14. 14.
    Schumer MC, Bartley CA, Bloch MH. Systematic review of pharmacological and behavioral treatments of skin picking disorder. J Clin Psychopharmacol. 2016;36(2):147–52.CrossRefGoogle Scholar
  15. 15.
    Selles RR, McGuire JF, Small BJ, et al. A systematic review and meta-analysis of psychiatric treatments for excoriation (skin-picking) disorder. Gen Hosp Psychiatry. 2016;41:29–37.CrossRefGoogle Scholar
  16. 16.
    McFarland K, Lapish CC, Kalivas PW. Prefrontal glutamate release into the core of the nucleus accumbens mediates cocaine-induced reinstatement of drug-seeking behaviour. J Neurosci. 2003;23(3):3531–7.CrossRefGoogle Scholar
  17. 17.
    Grant JE, Odlaug BL, Kim SW. Lamotrigine treatment of pathologic skin picking: an open label study. J Clin Psychiatry. 2007;68(9):1384–91.CrossRefGoogle Scholar
  18. 18.
    Arbabi M, Farnia V, Balighi K, et al. Efficiency of citalopram in treatment of pathological skin picking: a randomized double-blind placebo controlled trial. Acta Med Iran. 2008;46(5):367–72.Google Scholar
  19. 19.
    Grant JE, Odlaug BL, Chamberlain SR, et al. A double-blind placebo-controlled trial of lamotrigine for pathological skin picking: treatment efficacy and neurocognitive predictors of response. J Clin Psychopharmacol. 2010;30(4):396–403.CrossRefGoogle Scholar
  20. 20.
    Jafferany M, Osuagwu FC. Use of topiramate in skin picking disorder:a pilot study. Prim Care Companion CNS Disord. 2017;19(1).Google Scholar
  21. 21.
    Sasso DA, Kalanithi PS, Trueblood KV, et al. Beneficial effects of the glutamate-modulating agent riluzole on disordered eating and pathological skin-picking behaviors. J Clin Psychopharmacol. 2006;26(6):685–7.CrossRefGoogle Scholar
  22. 22.
    Grant JE, Chamberlain SR, Redden SA, et al. N-Acetylcysteine in the treatment of excoriation disorder: a randomized clinical trial. JAMA Psychiatry. 2016;73(5):490–6.CrossRefGoogle Scholar
  23. 23.
    Keuthen NJ, Jameson M, Loh R, et al. Open label trial of escitalopram treatment for pathological skin picking. Int Clin Psychopharmacol. 2007;22(5):268–74.CrossRefGoogle Scholar
  24. 24.
    Simeon D, Stein DJ, Gross S, et al. A double-blind trial of fluoxetine in pathologic skin picking. J Clin Psychiatry. 1997;58(8):341–7.CrossRefGoogle Scholar
  25. 25.
    Bloch MR, Elliott M, Thompson H, et al. Fluoxetine in pathological skin picking: open label and double-blind results. Psychosomatics. 2001;42(4):314–9.CrossRefGoogle Scholar
  26. 26.
    Arnold LM, Mutasim DF, Dwight MM, et al. An open clinical trial of fluvoxamine treatment of psychogenic excoriation. J Clin Psychopharmacol. 1999;19(1):15–8.CrossRefGoogle Scholar
  27. 27.
    Sharma H. Psychogenic excoriation responding to fluoxetine: a case report. J Indian Med Assoc. 2008;106(4):245–62.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Springer NatureAucklandNew Zealand

Personalised recommendations